ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Gastroenterology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,081Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 12

$345K Total Retail Price of All Prescriptions

Rank: 3 out of 12

221 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in District of Columbia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 221 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

5% of this provider’s 221 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

3% of this provider’s 4,585 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $207 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in District of Columbia
AMLODIPINE BESYLATE 243 233 1 2
QUETIAPINE FUMARATE 184 184 2 11
SIMVASTATIN 177 157 3 5
LISINOPRIL 173 149 4 3
FUROSEMIDE 157 153 5 13
METOPROLOL TARTRATE 151 140 6 15
RISPERIDONE 137 137 7 18
OMEPRAZOLE 133 121 8 1
JANTOVEN 115 97 9 20
LANTUS 99 69 10 22
CITALOPRAM HBR 96 84 11 23
BENZTROPINE MESYLATE 90 90 R 12 26
LEVOTHYROXINE SODIUM 90 90 12 17
LEVETIRACETAM 89 88 14 27
DONEPEZIL HCL 88 88 15 28
PANTOPRAZOLE SODIUM 85 71 16 6
ACETAMINOPHEN-CODEINE 84 66 S3 17 30
SERTRALINE HCL 84 83 17 30
LOVASTATIN 80 76 19 33
IBUPROFEN 73 71 20 19
SEROQUEL 66 66 21 36
DIVALPROEX SODIUM 61 49 22 39
TAMSULOSIN HCL 61 61 22 39
GABAPENTIN 60 59 24 41
HUMALOG 55 34 25 44
CLOPIDOGREL 54 40 26 47
OXYCODONE-ACETAMINOPHEN 52 47 S2 27 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.